GemVax & KAEL corrects largest shareholder stake to 11.95% in share collateral filing

• GemVax & KAEL corrected its disclosure on a share-pledge arrangement that could trigger a change in its largest shareholder.
• Largest shareholder Gem&Company stake revised to 5,433,132 shares, or 11.95%, from 5,456,126 shares, or 12.32%.
• Under full enforcement of pledged shares, holding revised to 3,643 shares, or 0.01%, from 26,637 shares, or 0.06%.
• Correction reflects an extension of a previously disclosed share-backed loan, resetting the pledge term to Oct. 1 to Dec. 30, 2026.
• Total borrowing tied to the pledges listed at KRW 44.86 billion, with total pledged amount KRW 66.77 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GemVax & KAEL Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261001900476), on October 01, 2026, and is solely responsible for the information contained therein.